Loading…
This event has ended. View the official site or create your own event → Check it out
This event has ended. Create your own
View analytic
Friday, May 2 • 11:45am - 12:45pm
Shedding Light on a Second-Line Advanced RCC Treatment: Importance of Adherence to Oral Medication

Sign up or log in to save this to your schedule and see who's attending!

Join your oncology nurse colleagues in attending this non-CNE promotional event sponsored by Pfizer Inc, spotlighting INLYTA® (axitinib) tablets as a treatment for patients with advanced renal cell carcinoma (RCC) after failure of one prior systemic therapy.

During this presentation, you will learn about the therapy, the indication, the product mechanism of action, clinical study results, and the benefits and risks of treatment. You will also learn about the importance of adherence to oral medication.

This is a Pfizer promotional activity. 

Seating is on a first-come, first-served basis. Please plan to arrive early to have the best chance at securing your seat. 

Speakers
JA

Julia A. Batten, APRN, MPH

Nurse Practitioner, Medical Oncology, Huntsman Cancer Institute


Friday May 2, 2014 11:45am - 12:45pm
Theater 1, Hall B Anaheim Convention Center, 800 W. Katella Avenue. Anaheim, CA 92802
  • CNE Status No CNE
  • Contact Hours of CNE: N/A